Moderna to Start Phase 3 Clinical Trial of Its Coronavirus Vaccine Candidate in July
Published
The biotech continues to race through the development of its potential SARS-CoV-2 vaccine.
Full ArticlePublished
The biotech continues to race through the development of its potential SARS-CoV-2 vaccine.
Full Article· Experts continue to study the coronavirus as the number of people it infects and kills rises each day.
· Scientists are..
· *Inovio has rallied 860% year-to-date as investors bid up the company's stock in hopes of the successful development of a..